1. Home
  2. NAT vs ABCL Comparison

NAT vs ABCL Comparison

Compare NAT & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nordic American Tankers Limited

NAT

Nordic American Tankers Limited

HOLD

Current Price

$5.72

Market Cap

914.8M

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$4.46

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAT
ABCL
Founded
1995
2012
Country
Bermuda
Canada
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
914.8M
1.1B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
NAT
ABCL
Price
$5.72
$4.46
Analyst Decision
Sell
Strong Buy
Analyst Count
2
5
Target Price
$4.00
$8.40
AVG Volume (30 Days)
4.7M
5.2M
Earning Date
05-28-2026
05-11-2026
Dividend Yield
8.50%
N/A
EPS Growth
N/A
10.91
EPS
N/A
N/A
Revenue
N/A
$75,128,000.00
Revenue This Year
$77.72
N/A
Revenue Next Year
N/A
$21.85
P/E Ratio
$525.49
N/A
Revenue Growth
N/A
160.56
52 Week Low
$2.54
$1.94
52 Week High
$6.34
$6.52

Technical Indicators

Market Signals
Indicator
NAT
ABCL
Relative Strength Index (RSI) 51.76 68.10
Support Level $5.39 $3.91
Resistance Level $6.30 $4.84
Average True Range (ATR) 0.25 0.25
MACD -0.04 0.03
Stochastic Oscillator 45.11 99.35

Price Performance

Historical Comparison
NAT
ABCL

About NAT Nordic American Tankers Limited

Nordic American Tankers Ltd owns and operates double-hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters according to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: